Introduction of unnatural amino acids into proteins using expressed protein ligation.

Here we describe the results of studies designed to explore the scope and limitations of expressed protein ligation (EPL), a protein semisynthesis approach that allows unnatural amino acids to be site specifically introduced into large proteins. Using Src homology 3 domains from the proteins c-Abl and c-Crk as model systems, we show here that EPL can be performed in the presence of moderate concentrations of the chemical denaturant, guanidine hydrochloride, and the organic solvent dimethylsulfoxide. Use of these solubilizing agents allowed the successful preparation of two semisynthetic proteins, 10 and 12, both of which could not be prepared using standard procedures due to the low solubility of the synthetic peptide reactants in aqueous buffers. We also report the results of thiolysis and kinetic studies which indicate that stable alkyl thioester derivatives of recombinant proteins can be generated for storage and purification purposes, and that 2-mercaptoethanesulfonic acid compares favorably with thiophenol as the thiol cofactor for EPL reactions, while having superior handling properties. Finally, we describe the semisynthesis of the fluorescein/rhodamine-containing construct (12) and the ketone-containing construct (14). The efficiency of these two syntheses indicates that EPL offers a facile way of incorporating these important types of biophysical and biochemical probes into proteins.

[1]  T. C. Evans,et al.  The in Vitro Ligation of Bacterially Expressed Proteins Using an Intein from Methanobacterium thermoautotrophicum * , 1999, The Journal of Biological Chemistry.

[2]  T. Muir,et al.  Insertion of a Synthetic Peptide into a Recombinant Protein Framework: A Protein Biosensor , 1999 .

[3]  D Cowburn,et al.  Chemical ligation of folded recombinant proteins: segmental isotopic labeling of domains for NMR studies. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[4]  H. Scheraga,et al.  Use of benzyl mercaptan for direct preparation of long polypeptide benzylthio esters as substrates of subtiligase. , 1999, Biochemical and biophysical research communications.

[5]  Francine B. Perler,et al.  InBase, the New England Biolabs Intein Database , 1999, Nucleic Acids Res..

[6]  A. Wlodawer,et al.  Total chemical synthesis and high-resolution crystal structure of the potent anti-HIV protein AOP-RANTES. , 1999, Chemistry & biology.

[7]  T. Muir,et al.  Chemical ligation of unprotected peptides directly from a solid support. , 2009, The journal of peptide research : official journal of the American Peptide Society.

[8]  C. Bertozzi,et al.  Synthesis of an oxime-linked neoglycopeptide with glycosylation-dependent activity similar to its native counterpart , 1998 .

[9]  T. C. Evans,et al.  Semisynthesis of cytotoxic proteins using a modified protein splicing element , 1998, Protein science : a publication of the Protein Society.

[10]  J. Tam,et al.  Methionine ligation strategy in the biomimetic synthesis of parathyroid hormones. , 1998, Biopolymers.

[11]  J. Tam,et al.  A biomimetic strategy in the synthesis and fragmentation of cyclic protein , 1998, Protein science : a publication of the Protein Society.

[12]  T. Muir,et al.  Expressed Protein Ligation, a Novel Method for Studying Protein-Protein Interactions in Transcription* , 1998, The Journal of Biological Chemistry.

[13]  T. Muir,et al.  Expressed protein ligation: a general method for protein engineering. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[14]  S. Kent,et al.  A novel method to synthesize cyclic peptides , 1998 .

[15]  Ming-Qun Xu,et al.  Modulation of Protein Splicing of the Saccharomyces cerevisiae Vacuolar Membrane ATPase Intein* , 1998, The Journal of Biological Chemistry.

[16]  T. Muir,et al.  Chemical Synthesis of a Circular Protein Domain: Evidence for Folding-Assisted Cyclization. , 1998, Angewandte Chemie.

[17]  R. Huber,et al.  Residue-specific bioincorporation of non-natural, biologically active amino acids into proteins as possible drug carriers: structure and stability of the per-thiaproline mutant of annexin V. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[18]  F. Perler,et al.  Protein splicing and autoproteolysis mechanisms. , 1997, Current opinion in chemical biology.

[19]  S. Kent,et al.  Total chemical synthesis of enzymatically active human type II secretory phospholipase A2. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[20]  F. Perler,et al.  Single-column purification of free recombinant proteins using a self-cleavable affinity tag derived from a protein splicing element. , 1997, Gene.

[21]  F. Quiocho,et al.  Crystal Structure of PI-SceI, a Homing Endonuclease with Protein Splicing Activity , 1997, Cell.

[22]  Philip E. Dawson,et al.  Modulation of Reactivity in Native Chemical Ligation through the Use of Thiol Additives , 1997 .

[23]  James P. Tam,et al.  Synthesis and Application of Unprotected Cyclic Peptides as Building Blocks for Peptide Dendrimers , 1997 .

[24]  B. Chait,et al.  Rapid, sensitive structure analysis of oligosaccharides. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[25]  M. Qasim,et al.  Probing intermolecular main chain hydrogen bonding in serine proteinase-protein inhibitor complexes: chemical synthesis of backbone-engineered turkey ovomucoid third domain. , 1997, Biochemistry.

[26]  J. Tam,et al.  Orthogonal coupling of unprotected peptide segments through histidyl amino terminus , 1997 .

[27]  T. Muir,et al.  Chemoselective backbone cyclization of unprotected peptides , 1997 .

[28]  T. Muir,et al.  Protein synthesis by chemical ligation of unprotected peptides in aqueous solution. , 1998, Methods in enzymology.

[29]  J. C. Parrish,et al.  Synergy in Protein Engineering , 1996, The Journal of Biological Chemistry.

[30]  G. Verdine,et al.  The leucine zipper domain controls the orientation of AP-1 in the NFAT.AP-1.DNA complex. , 1996, Chemistry & biology.

[31]  R. Barrett,et al.  AF12198, a Novel Low Molecular Weight Antagonist, Selectively Binds the Human Type I Interleukin (IL)-1 Receptor and Blocks in Vivo Responses to IL-1* , 1996, The Journal of Biological Chemistry.

[32]  P. Schultz,et al.  Site-specific protein modification using a ketone handle , 1996 .

[33]  L Serrano,et al.  Rational design of specific high-affinity peptide ligands for the Abl-SH3 domain. , 1996, Biochemistry.

[34]  C. Altenbach,et al.  Watching proteins move using site-directed spin labeling. , 1996, Structure.

[35]  S. Kent,et al.  EXTENDING THE APPLICABILITY OF NATIVE CHEMICAL LIGATION , 1996 .

[36]  Y. Anraku,et al.  Folding-dependent in vitro protein splicing of the Saccharomyces cerevisiae VMA1 protozyme. , 1996, Biochemical and biophysical research communications.

[37]  J. Tam,et al.  Acyl disulfide-mediated intramolecular acylation for orthogonal coupling between unprotected peptide segments. Mechanism and application , 1996 .

[38]  J. Tam,et al.  Peptide synthesis using unprotected peptides through orthogonal coupling methods. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[39]  J. Zheng,et al.  The solution structure of Abl SH3, and its relationship to SH2 in the SH(32) construct. , 1995, Structure.

[40]  Probing Protein Structure and Function with an Expanded Genetic Code , 1995 .

[41]  M. Mutter,et al.  Chemoselective ligation of multifunctional peptides to topological templates via thioether formation for TASP synthesis , 1995 .

[42]  A. Ferré-D’Amaré,et al.  TOTAL CHEMICAL SYNTHESIS OF A UNIQUE TRANSCRIPTION FACTOR-RELATED PROTEIN : CMYC-MAX , 1995 .

[43]  C. Wallace Peptide ligation and semisynthesis. , 1995, Current opinion in biotechnology.

[44]  J. Burnier,et al.  Subtiligase: a tool for semisynthesis of proteins. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[45]  J. Tom,et al.  A designed peptide ligase for total synthesis of ribonuclease A with unnatural catalytic residues. , 1994, Science.

[46]  Andrea Musacchio,et al.  High-resolution crystal structures of tyrosine kinase SH3 domains complexed with proline-rich peptides , 1994, Nature Structural Biology.

[47]  R. Ebright,et al.  Identification of the target of a transcription activator protein by protein-protein photocrosslinking. , 1994, Science.

[48]  T. Muir,et al.  Design and chemical synthesis of a neoprotein structural model for the cytoplasmic domain of a multisubunit cell-surface receptor: integrin alpha IIb beta 3 (platelet GPIIb-IIIa). , 1994, Biochemistry.

[49]  K. Rose,et al.  Chemo-enzymic backbone engineering of proteins. Site-specific incorporation of synthetic peptides that mimic the 64-74 disulfide loop of granulocyte colony-stimulating factor. , 1994, The Journal of biological chemistry.

[50]  K. Rose Facile synthesis of homogeneous artificial proteins , 1994 .

[51]  B. Neel,et al.  Solubilization and purification of enzymatically active glutathione S-transferase (pGEX) fusion proteins. , 1993, Analytical biochemistry.

[52]  K. Rose,et al.  Construction of protein analogues by site-specific condensation of unprotected fragments. , 1992, Bioconjugate chemistry.

[53]  S. Kent,et al.  Constructing proteins by dovetailing unprotected synthetic peptides: backbone-engineered HIV protease. , 1992, Science.

[54]  L. Leinwand,et al.  Expression of myosin and actin in Escherichia coli. , 1991, Methods in enzymology.

[55]  P G Schultz,et al.  A general method for site-specific incorporation of unnatural amino acids into proteins. , 1989, Science.

[56]  F. Lipmann,et al.  The Roots of Modern Biochemistry , 1988 .